Cel-Sci
CVM
#10574
Rank
A$48.83 M
Marketcap
A$2.78
Share price
-0.51%
Change (1 day)
-81.30%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of June 2026 : A$30.56 Million

According to Cel-Sci 's latest financial reports the company's total assets are A$30.56 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-09-30A$42.59 M9.13%
2024-09-30A$39.02 M-17.82%
2023-09-30A$47.49 M-39.54%
2022-09-30A$78.55 M-25.13%
2021-09-30A$0.10 B85.49%
2020-09-30A$56.56 M38.28%
2019-09-30A$40.9 M-0.13%
2018-09-30A$40.95 M40.17%
2017-09-30A$29.21 M-10.32%
2016-09-30A$32.58 M-20.01%
2015-09-30A$40.73 M85.07%
2014-09-30A$22 M89.27%
2013-09-30A$11.62 M-25.05%
2012-09-30A$15.51 M-18.85%
2011-09-30A$19.11 M-51.23%
2010-09-30A$39.19 M-26.04%
2009-09-30A$53 M185.95%
2008-09-30A$18.53 M-20.03%
2007-09-30A$23.17 M79.13%
2006-09-30A$12.94 M217.79%
2005-09-30A$4.07 M-47.06%
2004-09-30A$7.69 M79.05%
2003-09-30A$4.29 M-38.07%
2002-09-30A$6.93 M-24.33%
2001-09-30A$9.16 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$287.73 B 941,399.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$136.86 B 447,744.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.03 B 3,294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$27.14 M-11.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$57.03 B 186,536.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
A$0.79 B 2,512.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.59 B 5,129.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$9.03 M-70.43%๐Ÿ‡บ๐Ÿ‡ธ USA